Making best practice, everyday practice

Login Register

Diabetes and thromboembolic risk

Diabetes with comorbid kidney disease and/or AF significantly increases all-cause mortality and major cardiovascular events; NOACs show better renal protection and benefit for cardio/cerebrovascular risk than vitamin K antagonists

Read below to complete the CPD questions

 

 
WATCH THE ACCREDITED VIDEO AND READ THE SUMMARY REPORT
 

Do you like this? Share with a colleague